D
Dorthe Pedersen
Researcher at Aarhus University
Publications - 6
Citations - 1023
Dorthe Pedersen is an academic researcher from Aarhus University. The author has contributed to research in topics: Cancer & Chemotherapy. The author has an hindex of 6, co-authored 6 publications receiving 996 citations. Previous affiliations of Dorthe Pedersen include NIRAS.
Papers
More filters
Journal ArticleDOI
Leukemia following Hodgkin's disease.
John M. Kaldor,Nicholas Day,EA Clarke,Van Leeuwen Fe,Michel Henry-Amar,Fiorentino Mv,J. Bell,Dorthe Pedersen,Pierre R. Band,D. Assouline +9 more
TL;DR: It is concluded that chemotherapy for Hodgkin's disease greatly increases the risk of leukemia and that this increased risk appears to be dose-related and unaffected by concomitant radiotherapy.
Journal ArticleDOI
Leukemia Following Chemotherapy for Ovarian Cancer
John M. Kaldor,Nicholas E. Day,Folke Pettersson,E. Aileen Clarke,Dorthe Pedersen,Wolf Mehnert,J. Bell,Herman Høst,P. Prior,Sakari Karjalainen,Frank Neal,Maria Koch,Pierre R. Band,Won Choi,Vera Pompe Kirn,Annie Arslan,Birgitta Zarén,A. R. Belch,Hans H. Storm,Bernd Kittelmann,Patricia Fraser,Marilyn Stovall +21 more
TL;DR: The drugs cyclophosphamide, chlorambucil, melphalan, thiotepa, and treosulfan were independently associated with significantly increased risks of leukemia, as was the combination of doxorubicin hydrochloride and cisplatin.
Journal ArticleDOI
Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: A case—control study
John M. Kaldor,John M. Kaldor,Nicholas E. Day,Berndt Kittelmann,Folke Pettersson,Frøydis Langmark,Dorthe Pedersen,P. Prior,Frank Neal,Sakari Karjalainen,J. Bell,Won Choi,Maria Koch,Pierre R. Band,Vera Pompe-Kirn,Catherine Garton,Wolfhardt Staneczek,Birgitta Zarén,Marilyn Stovall,Paolo Boffetta +19 more
TL;DR: The estimated risk of bladder tumours due to cyclophosphamide was more than twice the risk following radiation to the bladder, and it appeared substantially earlier than in women treated for ovarian cancer, for both agents.
Journal ArticleDOI
Lung cancer following Hodgkin's disease: a case-control study.
John M. Kaldor,Nicholas Day,J. Bell,EA Clarke,F. Landmark,Sakari Karjalainen,Pierre R. Band,Dorthe Pedersen,Won Choi,V. Blair,Michel Henry-Amar,P. Prior,D. Assouline,Vera Pompe-Kirn,R. A. Cartwright,Maria Koch,Annie Arslan,Patricia Fraser,S. B. Sutcliffe,H. Host,Matti Hakama,Marilyn Stovall +21 more
TL;DR: A plausible inference from the study is that all forms of Hodgkin's disease therapy are carcinogenic to the lung and that chemotherapy is associated with an increase in risk which is at least comparable to and perhaps higher than the risk produced by radiotherapy.
Journal ArticleDOI
Leukemia following chemotherapy for ovarian cancer
John M. Kaldor,Nicholas Day,Folke Pettersson,EA Clarke,Dorthe Pedersen,Mehnert Wh,J. Bell,H. Host,P. Prior,Sakari Karjalainen,Frank Neal,Maria Koch,Pierre R. Band,Won Choi,V Pompe Kirn,Annie Arslan,Birgitta Zarén,A. R. Belch,Hans H. Storm +18 more
TL;DR: The drugs cyclophosphamide, chlorambucil, melphalan, thiotepa, and treosulfan were independently associated with significantly increased risks of leukemia, as was the combination of doxorubicin hydrochloride and cisplatin.